Specifically, before revascularization, 804 of 2,093 myocardial segments analyzed (38%) had abnormal contractility, and 694 segments (33%) had some areas of hyperenhancement. Among all 804 ...

U-II was found to increase afterload and reduce myocardial contractility. Its effect at high concentrations is best rationalized by myocardial ischemia. Using the calculations of Sunagawa et al.

Lignocaine has no effect on supraventricular tachycardia (SVT). Like most antiarrhythmic drugs, lignocaine depresses myocardial contractility, and toxic levels can produce paraesthesia, drowsiness, ...

Clinical feature in adults Transient depression of myocardial contractility; myocardial necrosis (cTnT elevation); arrhythmia Dilated cardiomyopathy; arrhythmia Dilated cardiomyopathy; arrhythmia ...

Istaroxime is designed as a positive inotropic agent that increases myocardial contractility through inhibition of Na+/K+- ATPase with a complimentary mechanism that facilitates myocardial ...

Concomitant methoxyflurane, trichloroethylene may depress myocardial contractility. Concomitant thyroxine may result in lower T 3 concentration. May block epinephrine. May interfere with glaucoma ...

Istaroxime is designed as a positive inotropic agent that increases myocardial contractility through inhibition of Na+/K+- ATPase with a complimentary mechanism that facilitates myocardial relaxation ...